Radiopharm Theranostics Limited (AU:RAD) has released an update.
Radiopharm Theranostics Ltd has disclosed that Point72 Associates, LLC holds a significant long equity derivative position in the company, specifically through a cash-settled equity swap involving over 54 million shares. This disclosure, made in compliance with Australian Takeovers Panel Guidance Note 20, indicates that Point72 does not have any other associates with long positions or relevant interests in Radiopharm nor does it hold any offsetting short positions.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.
